Images de page
PDF
ePub
[ocr errors]

FDA PROPOSALS TO EASE RESTRICTIONS ON
THE USE AND SALE OF EXPERIMENTAL DRUGS

NOV 13 1307

HEARING

BEFORE A

SUBCOMMITTEE OF THE
COMMITTEE ON

GOVERNMENT OPERATIONS

HOUSE OF REPRESENTATIVES

ONE HUNDREDTH CONGRESS

FIRST SESSION

APRIL 29, 1987

Printed for the use of the Committee on Government Operations

75-752

U.S. GOVERNMENT PRINTING OFFICE

WASHINGTON: 1987

For sale by the Superintendent of Documents, Congressional Sales Office
U.S. Government Printing Office, Washington, DC 20402

[blocks in formation]

KF 27
G664
19876

CONTENTS

Brook, Dr. Itzhak, professor of pediatrics and surgery, Uniformed Serv-

ices University of the Health Sciences, and chairman, FDA's Anti-

Infective Drugs Advisory Committee....

Cooper, Richard M., Esq., Chief Counsel, 1977-79, Food and Drug Admin-

istration....

Hirsch, Dr. Martin S., infectious disease unit, Department of Medicine,
Massachusetts General Hospital and Harvard Medical School, and
chairman, Steering Committee, AIDS Treatment Evaluation Program....
Moertel, Dr. Charles G., Purvis and Roberta Tabor Professor of Oncology,
Mayo Clinic and Mayo Medical School, and chairman, North Central
Cancer Treatment Group...

Raub, Dr. William F., Deputy Director, National Institutes of Health,

accompanied by Dr. William Friedewald, Associate Director for Disease

Prevention, Office of the Director; Dr. Maureen W. Myers, Chief, AIDS

Treatment Branch, National Institute for Allergy and Infectious Dis-

eases; and Dr. Charles R. McCarthy, Office for Protection from Re-

search Risks, Office of the Director

Robinson, Marty, member, Lavender Hill Mob, Lesbian and Gay Libera-
tion Movement, accompanied by Michael Petrelis

Weiss, Hon. Ted., a Representative in Congress from the State of New
York, and chairman, Human Resources and Intergovernmental Rela-
tions Subcommittee: Opening statement....

Young, Dr. Frank E., Commissioner, Food and Drug Administration,

accompanied by Dr. Paul D. Parkman, Acting Director, Center for

Drugs and Biologics; Dr. Donald B. Burlington, Acting Director, Divi-

sion of Biological Investigational New Drugs, Center for Drugs and

Biologics; Thomas Scarlett, General Counsel, Food and Drug Division;

Joseph A. Levitt, Executive Assistant to the Commissioner; and John

A. Norris, Deputy Commissioner.....

Letters, statements, etc., submitted for the record by:

Cooper, Richard M., Esq., Chief Counsel, 1977-79, Food and Drug Admin-

istration: Prepared statement...

Hirsch, Dr. Martin S., infectious disease unit, Department of Medicine,

Massachusetts General Hospital and Harvard Medical School, and

chairman, Steering Committee, AIDS Treatment Evaluation Program:

Prepared statement.....

[blocks in formation]

Moertel, Dr. Charles G., Purvis and Roberta Tabor Professor of Oncology,
Mayo Clinic and Mayo Medical School, and chairman, North Central
Cancer Treatment Group: Prepared statement....
Myers, Dr. Maureen W., Chief, AIDS Treatment Branch, National Insti-
tute for Allergy and Infectious Diseases: Information concerning
proposed regulations prior to their being announced on March 10............
Raub, Dr. William F., Deputy Director, National Institutes of Health:
Information concerning preclearance of a certain reproposal at any
NIH's Institutes

41-54

18

Robinson, Marty, member, Lavender Hill Mob, Lesbian and Gay Libera-
tion Movement: Prepared statement......

20

132-133

[ocr errors]
« PrécédentContinuer »